Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             63 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Accuracy and safety of pretest probability assessment of deep vein thrombosis by physicians in training using the explicit Wells clinical model PENALOZA, A.
2006
4 1 p. 278-281
artikel
2 Activation of p38 MAPKinase/cPLA2 pathway in homocysteine-treated platelets LEONCINI, G.
2006
4 1 p. 209-216
artikel
3 Adding the vessel wall to Virchow's triad MANN, K. G.
2006
4 1 p. 58-59
artikel
4 An association of candidate gene haplotypes and bleeding severity in von Willebrand disease type 2A, 2B, and 2M pedigrees KUNICKI, T. J.
2006
4 1 p. 137-147
artikel
5 Announcements 2006
4 1 p. 294
artikel
6 A novel compound heterozygous mutation in the F13A gene causing hereditary factor XIII deficiency in a Chinese family WU, S.
2006
4 1 p. 267-269
artikel
7 A prospective study of anticardiolipin antibodies as a risk factor for venous thrombosis in a general population (the HUNT study) NAESS, I. A.
2006
4 1 p. 44-49
artikel
8 A rapid enzyme-linked assay for ADAMTS-13 WU, J.-J
2006
4 1 p. 129-136
artikel
9 CHO cells expressing the high affinity αIIbβ3T562N integrin demonstrate enhanced adhesion under shear LEGENDRE, P.
2006
4 1 p. 236-246
artikel
10 Co-localization of von Willebrand factor with platelet thrombi, tissue factor and platelets with fibrin, and consistent presence of inflammatory cells in coronary thrombi obtained by an aspiration device from patients with acute myocardial infarction HOSHIBA, Y.
2006
4 1 p. 114-120
artikel
11 Combined use of clinical pretest probability and D-dimer test in cancer patients with clinically suspected deep venous thrombosis DI NISIO, M.
2006
4 1 p. 52-57
artikel
12 C-reactive protein contributes to the hypercoagulable state in coronary artery disease SONG, C. J.
2006
4 1 p. 98-106
artikel
13 Deficiency of thrombospondin-1 in mice does not affect adipose tissue development VOROS, G.
2006
4 1 p. 277-278
artikel
14 Discovery of thrombin activatable fibrinolysis inhibitor (TAFI) EATON, D.
2006
4 1 p. 260-261
artikel
15 Discovery of thrombin activatable fibrinolysis inhibitor (TAFI) HENDRIKS, D. F.
2006
4 1 p. 261-262
artikel
16 Discovery of thrombin activatable fibrinolysis inhibitor (TAFI) BERTINA, R. M.
2006
4 1 p. 256-257
artikel
17 Discovery of thrombin activatable fibrinolysis inhibitor (TAFI) CAMPBELL, W.
2006
4 1 p. 259
artikel
18 Discovery of thrombin activatable fibrinolysis inhibitor (TAFI) BOUMA, B. N.
2006
4 1 p. 257-258
artikel
19 Editorial MANNUCCI, P. M.
2006
4 1 p. 1-2
artikel
20 Evaluation of low PAI-1 activity as a risk factor for hemorrhagic diathesis ÅGREN, A.
2006
4 1 p. 201-208
artikel
21 Factor XIII (FXIII) and angiogenesis DARDIK, R.
2006
4 1 p. 19-25
artikel
22 Fatal thrombosis of antithrombin-deficient mice is rescued differently in the heart and liver by intercrossing with low tissue factor mice HAYASHI, M.
2006
4 1 p. 177-185
artikel
23 Fatty acid ethyl ester, a non-oxidative ethanol metabolite, reverses the inhibitory effect of ibuprofen on platelet aggregation SALEM, R. O.
2006
4 1 p. 275-276
artikel
24 Fixed dosage of low-molecular-weight heparins causes large individual variation in coagulability, only partly correlated to body weight AL DIERI, R.
2006
4 1 p. 83-89
artikel
25 Forthcoming articles in the February issue 2006
4 1 p. xv-xvi
artikel
26 Further evidence that fibrillar collagen is unable to promote platelet shape change and aggregation in the absence of secondary agonists. A rebuttal RIONDINO, S.
2006
4 1 p. 291-292
artikel
27 Further evidence that fibrillar collagen is unable to promote platelet shape change and aggregation in the absence of secondary agonists. Reply to a rebuttal OHLMANN, P.
2006
4 1 p. 292-293
artikel
28 Identification and characterization of murine alternatively spliced tissue factor BOGDANOV, V. Y.
2006
4 1 p. 158-167
artikel
29 Indicators of lifetime endogenous estrogen exposure and risk of venous thromboembolism SIMON, T.
2006
4 1 p. 71-76
artikel
30 Inherited defects of coagulation factor V: the hemorrhagic side ASSELTA, R.
2006
4 1 p. 26-34
artikel
31 Inherited defects of coagulation Factor V: the thrombotic side VOS, H. L.
2006
4 1 p. 35-40
artikel
32 Inhibition of 5-hydroxytryptamine2A receptor prevents occlusive thrombus formation on neointima of the rabbit femoral artery NISHIHIRA, K.
2006
4 1 p. 247-255
artikel
33 Is antithrombotic prophylaxis required in cancer patients with central venous catheters? No AGNELLI, G.
2006
4 1 p. 14-15
artikel
34 Is antithrombotic prophylaxis required in cancer patients with central venous catheters? Still an open question LEVINE, M.
2006
4 1 p. 16-18
artikel
35 Is antithrombotic prophylaxis required in cancer patients with central venous catheters? Yes for special patient groups HUISMAN, M. V.
2006
4 1 p. 10-13
artikel
36 Molecular bases of type II protein S deficiency: the I203-D204 deletion in the EGF4 domain alters GLA domain function BARONI, M.
2006
4 1 p. 186-191
artikel
37 More on: discovery of α2-plasmin inhibitor and its congenital deficiency GALLIMORE, M. J.
2006
4 1 p. 284-285
artikel
38 More on: pathogenic antibodies to coagulation factors. Part II: fibrinogen, prothrombin, thrombin, factor V, factor XI, factor XII, factor XIII, protein C and von Willebrand factor JONES, D. W.
2006
4 1 p. 282-284
artikel
39 More on: platelet count and the Use of Recombinant Factor VIIa for the treatment of Bleeding Complications after Hematopoietic Stem Cell Transplantation MARIETTA, M.
2006
4 1 p. 288
artikel
40 More on: the role of thrombin in gliomas ARBIT, E.
2006
4 1 p. 286
artikel
41 Mutations C1157F and C1234W of von Willebrand factor cause intracellular retention with defective multimerization and secretion HOMMAIS, A.
2006
4 1 p. 148-157
artikel
42 New epidemiological risk factors for venous thromboembolism (VTE) after menopause GRANDONE, E.
2006
4 1 p. 70
artikel
43 No significant improvement in diagnostic specificity of an anti-PF4/polyanion immunoassay with use of high heparin confirmatory procedure WARKENTIN, T. E.
2006
4 1 p. 281-282
artikel
44 Oral, direct Factor Xa inhibition with BAY 59-7939 for the prevention of venous thromboembolism after total hip replacement ERIKSSON, B. I.
2006
4 1 p. 121-128
artikel
45 Plasma D-dimer assays in the diagnosis of venous thromboembolism in cancer patients HUNT, B. J.
2006
4 1 p. 50-51
artikel
46 Platelet membrane glycoproteins: historical perspectives NURDEN, A. T.
2006
4 1 p. 3-9
artikel
47 Prerequisites for recombinant factor VIIa-induced thrombin generation in plasmas deficient in factors VIII, IX or XI LIVNAT, T.
2006
4 1 p. 192-200
artikel
48 Prophylaxis of venous thromboembolism in general and gynecologic day surgery in the Netherlands WASOWICZ-KEMPS, D. K.
2006
4 1 p. 269-271
artikel
49 Protein S binding to phospholipids: evaluation of eight variants of recombinant human protein S from the PROSIT study RAZZARI, C.
2006
4 1 p. 273-274
artikel
50 Reply to more on: the role of thrombin in gliomas HUA, Y.
2006
4 1 p. 287
artikel
51 Resistance to annexin A5 binding and anticoagulant activity in plasmas from patients with the antiphospholipid syndrome but not with syphilis WU, X.-X
2006
4 1 p. 271-273
artikel
52 Soluble intracellular adhesion molecule-1 is associated with cardiovascular disease risk and mortality in older adults JENNY, N. S.
2006
4 1 p. 107-113
artikel
53 Superficial thrombophlebitis of the legs: still a lot to learn. A rebuttal BOUNAMEAUX, H.
2006
4 1 p. 289
artikel
54 Superficial thrombophlebitis of the legs: still a lot to learn. Reply to a rebuttal DECOUSUS, H.
2006
4 1 p. 290
artikel
55 Synthesis of GPIbβ with novel transmembrane and cytoplasmic sequences in a Bernard–Soulier patient resulting in GPIb-defective signaling in CHO cells STRASSEL, C.
2006
4 1 p. 217-228
artikel
56 The cleaved and latent forms of antithrombin are normal constituents of blood plasma: a quantitative method to measure cleaved antithrombin KJELLBERG, M.
2006
4 1 p. 168-176
artikel
57 The importance of measuring anticardiolipin antibodies DE GROOT, P. G.
2006
4 1 p. 41-43
artikel
58 The reactivity of paired plasma and serum samples are comparable in the anticardiolipin and anti-β2-glycoprotein-1 ELISAs LEWIS, D. A.
2006
4 1 p. 265-267
artikel
59 The regulation of endothelial VWF secretion by nitric oxide: is it physiological? ZAREI, S.
2006
4 1 p. 263-265
artikel
60 The Ser219–>Gly dimorphism of the endothelial protein C receptor contributes to the higher soluble protein levels observed in individuals with the A3 haplotype QU, D.
2006
4 1 p. 229-235
artikel
61 Thrombin generation in vascular tissue PATHAK, A.
2006
4 1 p. 60-67
artikel
62 Treatment effects of high-dose antithrombin without concomitant heparin in patients with severe sepsis with or without disseminated intravascular coagulation KIENAST, J.
2006
4 1 p. 90-97
artikel
63 Treatment with combined oral contraceptives induces a rise in serum C-reactive protein in the absence of a general inflammatory response VAN ROOIJEN, M.
2006
4 1 p. 77-82
artikel
                             63 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland